CN Stock MarketDetailed Quotes

600993 Mayinglong Pharmaceutical Group

Watchlist
  • 25.63
  • +0.01+0.04%
Trading Nov 5 10:17 CST
11.05BMarket Cap22.90P/E (TTM)

Mayinglong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Hemorrhoids842.5M43.70%
Retail and wholesale income693.14M35.96%
Other315.37M16.36%
Other76.71M3.98%
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Pharmaceutical industry1.16B60.17%
Pharmaceutical commerce691.32M35.86%
Other76.57M3.97%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
Mainland China1.93B99.91%
Countries and regions outside the mainland of China1.78M0.09%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data